Steve Bunk | Jan 9, 2000 | 3 min read
Mounting evidence of estrogen's role in preventing cognitive decline is affecting women's decisions on hormone replacement therapy (HRT), a symposium panel recently told attendees of the Academy of Psychosomatic Medicine's annual meeting in New Orleans. But causes of variability among women in estrogen's impact on cognition have not yet been identified. Moreover, the continuing emergence of selective estrogen receptor modulators (SERMs), drugs that can imitate the hormone's positive effects whil